CLL cells exhibit elevated levels of CPT1 and CPT2, while inhibition of CPT induces compromised FAO activity due to ineffective transportation of fatty acids into mitochondria, subsequently leading to massive CLL cell death (141). The gene discussed is CPT2; the disease is B-cell chronic lymphocytic leukemia.